Patent ID: 11944627
Assignee: KURA ONCOLOGY, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 13:
14. The method of claim 1, wherein
R2 is selected from halogen, —OR52, N(R52)2, —CN, C1-3 alkyl, —CH2OR52, —CH2N(R52)2, C1-3 alkyl-N(R52)2, C1-3 haloalkyl, C2-3 alkenyl, and C2-3 alkynyl; and
R3 is selected from hydrogen, halogen, —OH, —N(R52)2, —CN, —C(O)OR52, C1-3 alkyl, and C1-3 haloalkyl.